ANBC, INC. (OTCPK: SYUP)
Health Care · Pharmaceuticals · CN
$—
— today · — 1Y
ANBC, INC. (OTCPK: SYUP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.92K and employs 0 people.
trading between 0.00 and 0.00.
Tweenvest scores ANBC, INC. across four factors: value 88/100. Its strongest factor is value.
SYUP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.92K
- Revenue (TTM)
- $50.95K
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -6.08
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 79.60M
- Employees
- 0
- Next earnings
- —
About ANBC, INC.
Shanghai Yutong Pharma, Inc., a company based in Shanghai, China, specializes in the development, manufacturing, and distribution of both traditional Chinese herbal remedies and cutting-edge biological pharmaceuticals within the People's Republic of China. Their diverse product portfolio addresses a wide range of health concerns. Noteworthy offerings include Qilisheng, crafted to strengthen the immune system and promote overall vitality. Oral solutions such as Qi-ju-di-huang are formulated to support kidney and liver function, while Qing-re-jie-du serves to reduce fever and alleviate heat. Sheng-mai-yin is designed to conserve vital energy and replenish bodily fluids, and Xiao-qing-long provides relief from coughs and difficulty breathing. The company also produces various syrups: Shen-bao targets the treatment of impotence and spermatorrhoea; Ban-xia offers cough suppression; and Gan-mao-zhi-ke combats symptoms of the flu, coughs, and nasal congestion. Further herbal preparations encompass Ban-lan-gen for common cold and influenza relief; Gan-mao-qing-re, which helps to mitigate minor body aches, pains, and fever; Huang-dan-yin-chen, utilized in managing jaundice and infectious hepatitis; and Liu-shen-qu, prescribed for instances of vomiting and dysentery. These pharmaceutical goods are supplied to distributors via a wholesale model.
- ISIN
- US00180L1052
- Founded
- 2003
- Listed since
- Jul 24, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.38 | +0.54% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.